Search research articles
Contact Us
Filters
Showing results (261-270 of 333) with videos related to
Page
of 34
Sort By:
Journal of Biological Response Modifiers
|
October 1, 1990
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity
J L Abbruzzese, B Levin, J A Ajani, et al.
British Journal of Cancer
|
November 1, 1976
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy
H Biran, J L Moake, R C Reed, et al.
The Journal of Clinical Investigation
|
August 1, 1974
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia
E M Hersh, J U Gutterman, G M Mavligit, et al.
Cancer
|
November 1, 1977
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival
G M Mavligit, J U Gutterman, M A Malahy, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Cancer
|
January 1, 1978
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia
K Ezaki, E M Hersh, M Keating, et al.
Nature
|
February 12, 1987
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
R Kurzrock, M Shtalrid, P Romero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction
J A Ajani, J A Roth, M B Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer
L L Danhauser, J H Freimann, T L Gilchrist, et al.
Cancer Treatment Reports
|
November 1, 1978
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin
G N Hortobagyi, H Y Yap, G R Blumenschein, et al.
Page
of 34
Search research articles
Search
Showing results (261-270 of 333) with videos related to
Sort By:
Page
of 34
Journal of Biological Response Modifiers
|
October 1, 1990
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity
J L Abbruzzese, B Levin, J A Ajani, et al.
British Journal of Cancer
|
November 1, 1976
Complement activation in vivo in cancer patients receiving C. parvum immunotherapy
H Biran, J L Moake, R C Reed, et al.
The Journal of Clinical Investigation
|
August 1, 1974
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia
E M Hersh, J U Gutterman, G M Mavligit, et al.
Cancer
|
November 1, 1977
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival
G M Mavligit, J U Gutterman, M A Malahy, et al.
Cancer
|
February 1, 1987
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection
L M Itri, M Campion, R A Dennin, et al.
Cancer
|
January 1, 1978
Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia
K Ezaki, E M Hersh, M Keating, et al.
Nature
|
February 12, 1987
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
R Kurzrock, M Shtalrid, P Romero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction
J A Ajani, J A Roth, M B Ryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1993
Phase I and plasma pharmacokinetic study of infusional fluorouracil combined with recombinant interferon alfa-2b in patients with advanced cancer
L L Danhauser, J H Freimann, T L Gilchrist, et al.
Cancer Treatment Reports
|
November 1, 1978
Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin
G N Hortobagyi, H Y Yap, G R Blumenschein, et al.
Page
of 34